
Recent studies highlight its distinct genetic profile, including chromosomal abnormalities, miRNA expression, and tumor microenvironment changes. Despite therapeutic advances, treatment challenges persist, especially in advanced-stage disease. Larger clinical trials and robust translational research are crucial for refining diagnostic and therapeutic protocols to improve prognosis and patient outcomes in conjunctival melanoma.
Like
Save
Share